Clincosm LogoSign in Get a demo

Investigation of Arm Swings Characteristics in Patient With Chronic Obstructive Pulmonary Disease

Sponsor
Hacettepe University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05746702
Collaborator
(none)
40
Enrollment
19.6
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The former aim of this study is to determine whether the arm swings change in patients with Chronic Obstructive Pulmonary Disease (COPD) according to healthy subjects. The latter purposes to investigate the correlation between balance parameters and arm swing, how to change arm swing according to severity of the disease, and to determine the relationship between balance and the severity of disease, the relationship of posture both arm swing and severity of disease in patients with COPD. In accordance with this purposes, 20 patients with COPD who have Global Initiative for Chronic Obstruction Lung Disease (GOLD) stage 1-2-3 and 20 healthy controls will be included between the ages of 40 and 65, respectively. Tests and questionnaires will be used in order to determine the severity of COPD and to evaluate posture. Berg Balance Scale, Time Up and Go Test, 6 Minute Pegboard and Ring Test, 6 Minute Walk Test and gait analysis will be performed. It is expected that by determining the parameters that can be affected by severity of COPD. It is estimate to have information about severity of the disease by means of observational analysis. It will guide professional working in the field.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Kronik Obstrüktif Akciğer Hastalığında Yürüyüş Sırasında Yürüyüşün Zaman Mesafe Karakteristikleri ve Kol Salınımlarının İncelenmesi
    Anticipated Study Start Date :
    Mar 1, 2023
    Anticipated Primary Completion Date :
    Jun 19, 2024
    Anticipated Study Completion Date :
    Oct 19, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Arm Swings Characteristics [1 day]

      Change of the arm swings during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.

    Secondary Outcome Measures

    1. Spatiotemporal Characteristic [1 day]

      Change of the spatiotemporal characteristic during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.

    2. Upper Extremity Functional Capacity [1 day]

      Upper extremity functional capacity by 6 minute pegboard and ring test in patient with Chronic Obstructive Pulmonary Disease

    3. Balance [1 day]

      Balance by Berg Balance Scale and Time Up Go Test in patient with Chronic Obstructive Pulmonary Disease

    4. Severity of Disease [1 day]

      severity of disease by GOLD ( Global İnitiative for Chronic Obstructive Pulmonary Disease) , CAT ( Chronic Respiratory Questionnaire), Pulmonary Function Test in patient with Chronic Obstructive Pulmonary Disease

    5. Posture [1 day]

      posture by Corbin Posture Analyses Form in patient with Chronic Obstructive Pulmonary Disease

    6. Functional Exercise Capacity [1 day]

      Functional exercise capacity by six minute gait test in patients with Chronic Obstructive Pulmonary Disease.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Who has been clinically stable for the last 4 weeks,

    • who will be able to walk independently for 6 minutes,

    • According to the Classification of Airflow Limitation in COPD (GOLD) system, the Stage is 1-2-3,

    • who declares that he has not taken part in any other research

    Exclusion Criteria:

    • walking assistive devices,

    • receiving chronic oxygen therapy,

    • with central and peripheral vestibular disease,

    • with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance,

    • with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery,

    • who has communication problems,

    • with mental and cognitive problems

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Aynur Demirel, PT, PhD, Assoc. Prof., Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT05746702
    Other Study ID Numbers:
    • GO 22/903
    First Posted:
    Feb 28, 2023
    Last Update Posted:
    Feb 28, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Lung Diseases
    Lung Diseases, Obstructive
    Pulmonary Disease, Chronic Obstructive
    Dyspnea
    Gait Disorders, Neurologic

    Study Results

    No Results Posted as of Feb 28, 2023